EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endocannabinoid Enhancement via MAGL Inhibition in CDKL5 Deficiency: Selective Cellular Benefits and Domain-Specific Functional Effects in Adult Cdkl5 KO Mice

Manuela Loi iD, Nicola Mottolese iD, Giorgio Medici, Feliciana Iannibelli, Nicolò Interino iD, Giulia Candini iD, Federica Trebbi, Angelica Marina Bove, Jessica Fiori, Stefania Trazzi iD, Elisabetta Ciani iD

International Journal of Molecular Sciences · 19.03.2026 · 27 (6) · 2773

DOI: 10.3390/ijms27062773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.03.2026. Verfasst von Manuela Loi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Neuromotor Science, University of Bologna, 40126 Bologna, Italy. Hauptthemen laut MEDLINE: Monoacylglycerol Lipases, Endocannabinoids, Protein Serine-Threonine Kinases, Spasms, Infantile. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CDKL5 Insieme verso la Cura Onlus, University of Bologna, Italian parent association “CDKL5 Insieme verso la cura”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CDKL5 Deficiency Disorder (CDD) is a severe neurodevelopmental encephalopathy characterized by early disruptions of synaptic maturation and network stability, leading to persistent motor, cognitive, and behavioral impairments. Given the role of the endocannabinoid system in synaptic development, neuroinflammation, and neuronal resilience, we investigated whether the sustained enhancement of endogenous 2-arachidonoylglycerol (2-AG) signaling via monoacylglycerol lipase (MAGL) inhibition could mitigate key pathological features in adult Cdkl5 knockout (KO) mice. Using an intermittent 6-week treatment, the MAGL inhibitor JZL184 robustly increased plasma 2-AG levels, reduced MAGL protein levels, and activated CB1-AKT signaling without evidence of receptor desensitization. Despite this clear pharmacodynamic efficacy, behavioral effects were domain-specific: neither dose ameliorated core behavioral deficits, although the higher dose selectively reduced stereotypic jumping and modestly improved cue-dependent associative memory. At the cellular level, JZL184 induced biologically meaningful effects, partially restoring dendritic spine maturation in the primary somatosensory cortex and increasing neuronal survival in the vulnerable CA1 hippocampal region. In contrast, microglial responses were dose-dependent and divergent, with the lower dose exerting anti-inflammatory effects, while the higher dose increased cortical microglial density and Allograft Inflammatory Factor-1 (AIF-1) expression, suggesting engagement of compensatory or off-target mechanisms. Overall, these findings show that MAGL inhibition activates neuroprotective pathways and ameliorates select structural deficits in adult Cdkl5 KO mice, but is insufficient to produce broad behavioral recovery, highlighting the domain-specific effects of selective 2-AG enhancement via MAGL inhibition and the need for developmentally informed or multimodal therapeutic strategies in CDD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monoacylglycerol LipasesEndocannabinoidsProtein Serine-Threonine KinasesSpasms, InfantileBenzodioxolesPiperidinesEpileptic SyndromesAnimalsMice, KnockoutMiceGlyceridesMaleArachidonic AcidsMicrogliaSignal Transduction

Stichwörter der Autor:innen

CDKL5 deficiency disorderMAGL inhibitionendocannabinoid systemmicroglial activation and neuroinflammationsynaptic maturation and neuroprotection

Substanzen

Monoacylglycerol LipasesEndocannabinoidsProtein Serine-Threonine KinasesCDKL5 protein, mouseBenzodioxolesPiperidinesJZL 184Glyceridesglyceryl 2-arachidonateArachidonic Acids

Autor:innen und Institutionen

  • Department of Biomedical and Neuromotor Science, University of Bologna, 40126 Bologna, Italy.
  • IRCCS Istituto Delle Scienze Neurologiche di Bologna, 40139 Bologna, Italy.
  • Department of Chemistry "G. Ciamician", University of Bologna, 40126 Bologna, Italy.

ORCID-Profile: Manuela Loi, Nicola Mottolese, Nicolò Interino, Giulia Candini, Stefania Trazzi, Elisabetta Ciani

Förderung

  • CDKL5 Insieme verso la Cura Onlus
  • University of Bologna
  • Italian parent association “CDKL5 Insieme verso la cura”

Zitieren

APA

Loi, M., Mottolese, N., Medici, G., Iannibelli, F., Interino, N., Candini, G., Trebbi, F., Bove, A. M., Fiori, J., Trazzi, S., & Ciani, E. (2026). Endocannabinoid Enhancement via MAGL Inhibition in CDKL5 Deficiency: Selective Cellular Benefits and Domain-Specific Functional Effects in Adult Cdkl5 KO Mice. International Journal of Molecular Sciences, 27(6), 2773. https://doi.org/10.3390/ijms27062773

Vancouver

Loi M, Mottolese N, Medici G, Iannibelli F, Interino N, Candini G, et al. Endocannabinoid Enhancement via MAGL Inhibition in CDKL5 Deficiency: Selective Cellular Benefits and Domain-Specific Functional Effects in Adult Cdkl5 KO Mice. International Journal of Molecular Sciences. 2026;27(6):2773. doi:10.3390/ijms27062773

BibTeX
@article{Loi2026,
  author = {Loi, Manuela and Mottolese, Nicola and Medici, Giorgio and Iannibelli, Feliciana and Interino, Nicolò and Candini, Giulia and Trebbi, Federica and Bove, Angelica Marina and Fiori, Jessica and Trazzi, Stefania and Ciani, Elisabetta},
  title = {Endocannabinoid Enhancement via MAGL Inhibition in CDKL5 Deficiency: Selective Cellular Benefits and Domain-Specific Functional Effects in Adult Cdkl5 KO Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2773},
  doi = {10.3390/ijms27062773}
}
Kostenlos starten →